Swiss drugmaker Novartis reported a 6% gain in fourth-quarter adjusted net income on Wednesday, helped by cost cuts and strong growth of recently launched drugs. Core net income for the quarter came in at $3.13 billion, it said in a statement, missing analysts' estimate of about $3.3 billion, as per LSEG data. Novartis also extended its mid-term guidance, saying it expected sales to grow 5% per year until 2028, when adjusting for currency swings.
Germany s health ministry
said on Tuesday any changes to a law that keeps the health
insurance system from paying for weight-loss drugs were not on
the agenda, dismissing remarks by an Eli Lilly.
Germany's health ministry has no plans to change a law that prevents the health insurance system from paying for weight-loss drugs, it said on Tuesday, dismissing remarks by an Eli Lilly executive of talks that may lead to a relaxing of the ban. "There are currently no plans to change the policy on coverage of pharmaceuticals for weight loss," a ministry spokesperson said in a statement, responding to a request from Reuters. The policy affects statutory health plans overseen by the state that co
Germany s health ministry has no plans to change a law that prevents the health insurance system from paying for weight-loss drugs, it said on Tuesday, dismissing remarks by an Eli Lilly executive. -January 30, 2024 at 07:07 am EST
- MarketScreener
Germany's health ministry has no plans to change a law that prevents the health insurance system from paying for weight-loss drugs, it said on Tuesday, dismissing remarks by.